Covexe vs RevMan

Covexe is a browser-based platform for systematic reviews, meta-analysis, evidence synthesis, and applied statistics. Its review workflow spans question and search, screening, full-text review, extraction, appraisal, synthesis, and reporting. It supports systematic, scoping, network meta-analysis, diagnostic accuracy, umbrella, rapid, and narrative reviews. Methods include pairwise and network meta-analysis, GRADE ratings, risk-of-bias tools, and a PRISMA 2020 flow diagram; the statistics suite covers regression, survival analysis, diagnostic accuracy, and other methods checked against R packages and implementations. References can be imported in RIS, NBIB, BibTeX, PubMed XML, CSV, and Excel formats, with duplicates detected by DOI and PMID. Users can connect their own OpenAI, Anthropic, or Google AI key. The co-pilot pauses for approval at checkpoints, and AI screening will not exclude a study without user approval. Signed-out work stays in the browser; signed-in reviews are stored for cloud sync and sharing. The free plan costs nothing, while Pro costs $99 a year. Team costs $150 a year per seat with a three-seat minimum.

RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.